JPMorgan (JPM) reduced lending to Jane Street for bond trading in 2025 as the US bank pushed into bond trading, according to FT
Newsquawk Staff ·
JPMorgan (JPM) reduced lending to Jane Street for bond trading in 2025 as the US bank pushed into bond trading, according to FT.
What it means
Prime brokers pulling or trimming credit lines to clients whose businesses overlap with their own is a long-running tension in the financing world: banks want the balances and flows that big prop trading clients bring, but competing desks inside the same house create obvious conflicts, and episodes of this kind have tended to surface when a bank is building share in the very product the client dominates. The mechanism here is specific: repo and secured financing for bond market-making inventory, where the size and pricing of a line directly shapes how much balance sheet a market maker can run, so a reduction by one major lender matters most if it is not replaced elsewhere at similar terms. Historically, large electronic market makers have been diversified across multiple financing counterparties precisely because single-bank dependence is a known vulnerability, and the usual sequence after such a move is quiet reallocation of the facility rather than any visible disruption. The distinction worth drawing is between a commercial decision driven by competition and one driven by risk appetite toward the client or the asset class; the former is idiosyncratic, the latter would be a tell about bank willingness to finance leveraged fixed income more broadly. Worth noting is whether peer banks absorb the line and whether financing spreads in Treasury and credit repo show any strain, which is where a wider pullback would first appear.
Sources
- Week in Focus 26-30th October 2026: FOMC, BoC, RBNZ, ECB, BoJ Policy Decisions, US PCE
- US Midterm Preview: Democrats Favoured to Flip the House, Senate Too Close to Call
- Newsquawk Weekly Economic Release 26th - 30th October 2026
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM
- Citi (C) has been granted approval by China for its securities unit
Related headlines
- Newsquawk European Market Wrap - 23rd October 202613 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease7 hours ago
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED7 hours ago
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post7 hours ago
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans8 hours ago
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL9 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS10 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 202710 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system11 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter11 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)12 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed12 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce13 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders13 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer13 hours ago